EPW.CN - Empower Clinics Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.1200
0.0000 (0.00%)
At close: 2:53PM EST
Stock chart is not supported by your current browser
Previous Close0.1200
Open0.1200
Bid0.12 x 0
Ask0.12 x 0
Day's Range0.1200 - 0.1200
52 Week Range0.0350 - 0.5100
Volume3,000
Avg. Volume77,094
Market Cap9.291M
Beta (3Y Monthly)6.73
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire10 days ago

    Datametrex Announces Cannabis AI Pilot Program With Empower

    Datametrex AI Limited (DM.V) (the “Company” or “Datametrex”) is pleased to announce its agreement to partner with EMPOWER CLINICS INC. (CSE: EPW) (“Empower”) through its subsidiary Canntop AI Inc. (“Canntop”) on the creation of a pilot program (“Pilot”) using Artificial Intelligence (“AI”) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. This is to identify improvements and efficacy in long-term patient care. Empower intends to use Canntop’s AI platform to gain actionable insights on how consumer social data is generating nationwide interest in CBD based products, alternative pain management options and the use of cannabis-based therapies.

  • Empower Announces AI Pilot Program
    CNW Group10 days ago

    Empower Announces AI Pilot Program

    VANCOUVER , Feb. 5, 2019 /CNW/ - EMPOWER CLINICS INC. (EPW.CN) ( Frankfurt 8EC) ("Empower" or the "Company") today announces it intends to partner with Datametrex AI Limited ("Datametrex") and its subsidiary, Canntop AI Inc. ("Canntop"), to create a pilot program that uses Artificial Intelligence (AI) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. The pilot program is expected to utilize Empower patient data in a HIPAA compliant manner, to determine if normalized data can be generated using Datametrex AI solutions to understand how patient care and efficacy of physician-guided treatment recommendations are positively impacting serious qualifying conditions of patients.

  • Empower Clinics Announces Major Acquisition
    CNW Group18 days ago

    Empower Clinics Announces Major Acquisition

    VANCOUVER , Jan. 28, 2019 /CNW/ - EMPOWER CLINICS INC. (EPW.CN) ( Frankfurt 8EC) ("Empower" or the "Company") today announces it has entered into a non-binding term sheet to acquire the business of Sun Valley Certification Clinics Holdings LLC (" Sun Valley "), including its interests in certain affiliates thereof, by way of a share or asset acquisition, subject to due diligence and customary closing conditions. Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona , one clinic in Las Vegas , a tele-medicine platform serving California , and a fully developed franchise business model for the domestic cannabis industry, which is believed to be the first of its kind in the United States . The proposed transaction is expected to create one of the largest clinic groups in the medical cannabis sector in the United States , with twelve physical locations having a combined patient count of 165,000 patients in Washington , Oregon , Illinois , Arizona , Nevada and California , and the potential to rapidly expand the clinic network via the Sun Valley franchise program.

  • Empower Clinics Provides Corporate Update
    CNW Group29 days ago

    Empower Clinics Provides Corporate Update

    SEATTLE, WA , Jan. 17, 2019 /CNW/ - EMPOWER CLINICS INC. (EPW.CN) ( Frankfurt 8EC) ("Empower" or the "Company") today provided a corporate update on operations and changes to its board of directors. The Company is pleased to announce its first production run of Sollievo CBD lotion has commenced selling in two test markets - Portland, OR and Seattle, WA.

  • Business Wire3 months ago

    Empower Clinics to Launch Telemedicine Platform for Medical Cannabis, Wellness Treatment

    Empower Clinics Inc. (https://www.empowerclinics.com), (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it is nearing completion of a telemedicine platform that will enable interested patients worldwide to connect with its specialized medical doctors. Expected to launch in December via Empower’s Website, the telemedicine offering will make it easy for patients worldwide to speak directly with medical doctors about anything related to cannabis-based treatments as well as overall wellness. “Telemedicine leverages two of Empower’s greatest assets, in bringing together technology with Empower’s highly specialized medical doctors to provide patients with the expertise they need where and when they want it,” said Craig Snyder, Empower CEO.

  • Business Wire3 months ago

    Empower Clinics Salutes Military Veterans with 50% Discounts at Chicago Medical Cannabis and Wellness Clinic

    Empower Clinics Inc. (https://www.empowerclinics.com) (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that its recently opened clinic in downtown Chicago will honor all US military veterans by offering 50% discounts on its services through the end of 2018. One of Empower Clinics’ main focuses is helping military veterans obtain medical cannabis registry cards for treatment of Post-Traumatic Stress Disorder (PTSD) and its side effects associated with pain, sleep and stress. Empower’s medical doctors and staff can guide veterans through the state of Illinois’ 40 qualifying conditions, physician certification and registry card application forms required by the Illinois Department of Public Health.

  • Business Wire4 months ago

    Empower Clinics and Inolife R&D Announce Letter of Intent for US Distribution Agreement for Needle-free Treatments

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has signed a letter of intent for a national distribution agreement with Inolife R&D, an emerging specialty medical device company. Under the agreement, Empower Clinics will make Inolife’s pioneering needle-free injection devices available to patients at Empower’s 15 clinics in Oregon, Washington, and Illinois. Inolife developed its Inojex 30 and Nanojex devices to be easy-to-use, safe, pain-free, and more efficient in delivering treatment to patients than is possible with traditional needle-based injections.

  • Empower Clinics to Launch CBD Medical Cannabis Products under “Sollievo” Brand throughout North America
    Business Wire4 months ago

    Empower Clinics to Launch CBD Medical Cannabis Products under “Sollievo” Brand throughout North America

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a comprehensive agreement with Titration Technologies, LLC, an innovator in cannabis product development, to manufacture, package, and fulfill Empower’s “Sollievo” CBD medical cannabis products throughout North America. As part of the agreement, Titration will produce Empower-formulated CBD medical cannabis products, which Empower will sell under its “Sollievo” product brand on Empower’s Website, at Empower clinics, as well as select third-party wellness clinics throughout the US and Canada. “This agreement enables patients in all 50 states and Canada to access Empower’s CBD products, which is an important milestone as we continue to expand our business and service areas,” said Craig Snyder, Empower CEO.

  • Business Wire4 months ago

    Empower Clinics Announces US Distribution Agreement with Integrated Cannabis Company

    FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a national distribution agreement with Integrated Cannabis Company, Inc. (ICAN.CN) (ICNAF). Both companies have engaged with their marketing and distribution teams to streamline the logistics of rolling out new products in the Empower clinics. The CBD products are non-psychotropic: they do not directly affect mood, perception, or consciousness.

  • Business Wire4 months ago

    Empower Clinics CEO to Address State of the Cannabis Industry Conference

    Empower Clinics Inc. (EPWCF) (EPW.CN) (8EC.F), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that CEO Craig Snyder will participate in a leadership panel presentation, “How Tech & Data are Shaping the Industry,” as part of the second annual State of the Cannabis Industry Conference to be held in Boston on October 4. New York City-based Viridian Capital Advisors, a financial and strategic advisory firm dedicated to the cannabis industry, and Burns & Levinson LLP, a Boston law firm at the forefront of advising national businesses in the cannabis space, are presenting the second annual State of the Cannabis Industry Conference: Growth Opportunities for Professionals, Operators, and Investors. This invitation-only event explores opportunities in the rapidly growing, multi-billion-dollar cannabis industry and investment considerations for professional investors.

  • Business Wire5 months ago

    Empower Clinics Encouraged by US Drug Enforcement Administration’s (DEA) Decision on CBD-based Treatment

    FRA 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today issued a statement regarding the US Department of Justice and Drug Enforcement Agency’s (DEA) decision late last week to place a cannabidiol (CBD)-based treatment, Epidiolex, in schedule V of the Controlled Substances Act (CSA), the least restrictive schedule of the CSA. In June, the Food and Drug Administration (FDA) announced that it approved Epidiolex for treating two severe form of epilepsy. “We are very encouraged by this move, as we believe it will set the stage for potentially more Federally approved medications with CBD,” said Craig Snyder, Empower CEO.

  • Business Wire5 months ago

    Empower Clinics Announces Escrow Lock-Up Agreements with Company Insiders Covering More Than 40% of Outstanding Shares

    FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that officers of the company, as well as significant founding shareholders of Empower’s predecessor company, have entered a three-year escrow related to the company common shares that represent more than 40% of the company’s currently issued and outstanding shares. The escrow agreements provide that these shareholders will not sell or otherwise dispose of any shares, or enter into any transaction to such effect, directly or indirectly, unless detailed provisions of the escrow are met. The company also announced that it intends to close a non-brokered private placement (the “Offering”) of an aggregate principal amount of $575,060 in convertible debentures (the “Convertible Debentures”).

  • Empower Clinics to Open Chicago Medical Cannabis and Wellness Clinic
    Business Wire5 months ago

    Empower Clinics to Open Chicago Medical Cannabis and Wellness Clinic

    FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has established a new clinic in downtown Chicago, as part of the company’s national expansion. This follows the late August signature of a statewide measure by Illinois’ governor to expand access to medical cannabis as an alternative for opioid painkillers. Located in downtown Chicago at 160 N. Upper Wacker Drive, the clinic is slated to open on September 24 and be staffed by licensed medical professionals and support personnel.

  • Business Wire5 months ago

    Empower Clinics Announces Listing on Frankfurt Stock Exchange

    “As we plan to accelerate our activity in international cannabis and wellness markets, Empower’s listing on the Frankfurt Stock Exchange is a key step in enabling European investors to participate in this expansion,” said Craig Snyder, Empower CEO.

  • Business Wire8 months ago

    Empower Clinics Announces Stock Option Grant and Private Placement Financing

    Empower Clinics Inc. (EPW.CN), a leading owner and operator of medical cannabis clinics in the US, announced today that it has granted an aggregate of 3,850,000 stock options to certain officers, directors, employees and consultants of the company, subject to approval of the Canadian Securities Exchange (the “CSE”). The options vest immediately, are exercisable at CDN $0.38 per common share, will expire on May 25, 2023 and are otherwise governed by the terms and conditions of the company's stock option plan. Following the grant of the options, the company has a total of 7,150,000 stock options outstanding representing approximately 10% of the outstanding common shares of the company.

  • Business Wire9 months ago

    Empower Clinics Announces Medical Cannabis Product Distribution Agreement in Oregon

    Empower Clinics Inc. (EPW.CN), a leading owner and operator of medical cannabis clinics in the US, today announced that it has signed a distribution agreement with Nova Paths, an innovator in cannabis product development and distribution, to manufacture and sell medical cannabis products to Oregon dispensaries. As part of the agreement, Nova Paths, a licensed wholesaler, will produce and sell medical cannabis products under the Empower product brand, Sollievo. Under terms of the agreement, Nova Paths will make monthly royalty payments to Empower based on product sales.

  • Business Wire9 months ago

    Empower Clinics Adds Brand and Marketing Pioneer Peter McDonough to Board of Directors

    Empower Clinics Inc. (EPW.CN), a leading owner and operator of medical cannabis clinics in the US, today announced that Peter McDonough, one of the world’s leading brand and marketing executives, has joined its Board of Directors, effective immediately. McDonough has more than 30 years leadership experience in building and managing some of the world’s most iconic brands. In 2015 McDonough completed his tenure as President, Chief Marketing Officer, and Chief Innovation Officer for Diageo North America, where his portfolio included the top two largest spirits brands in the world, Johnnie Walker and Smirnoff, as well as 20 of the world’s top 100 spirits brands.